annual EBITDA:
$7.76B-$7.04B(-47.54%)Summary
- As of today (April 18, 2025), AMGN annual EBITDA is $7.76 billion, with the most recent change of -$7.04 billion (-47.54%) on December 31, 2024.
- During the last 3 years, AMGN annual EBITDA has fallen by -$3.53 billion (-31.27%).
- AMGN annual EBITDA is now -47.54% below its all-time high of $14.80 billion, reached on December 31, 2023.
Performance
AMGN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$1.53B-$3.74B(-71.00%)Summary
- As of today (April 18, 2025), AMGN quarterly EBITDA is $1.53 billion, with the most recent change of -$3.74 billion (-71.00%) on December 31, 2024.
- Over the past year, AMGN quarterly EBITDA has dropped by -$1.52 billion (-49.92%).
- AMGN quarterly EBITDA is now -71.00% below its all-time high of $5.27 billion, reached on September 30, 2024.
Performance
AMGN quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$11.96B-$1.52B(-11.30%)Summary
- As of today (April 18, 2025), AMGN TTM EBITDA is $11.96 billion, with the most recent change of -$1.52 billion (-11.30%) on December 31, 2024.
- Over the past year, AMGN TTM EBITDA has dropped by -$2.84 billion (-19.20%).
- AMGN TTM EBITDA is now -19.32% below its all-time high of $14.82 billion, reached on September 30, 2023.
Performance
AMGN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AMGN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -47.5% | -49.9% | -19.2% |
| 3 y3 years | -31.3% | -53.9% | +5.9% |
| 5 y5 years | -38.5% | -48.8% | -6.2% |
AMGN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -47.5% | at low | -71.0% | at low | -19.3% | +7.5% |
| 5 y | 5-year | -47.5% | at low | -71.0% | at low | -19.3% | +8.3% |
| alltime | all time | -47.5% | >+9999.0% | -71.0% | +2322.4% | -19.3% | >+9999.0% |
Amgen EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $7.76B(-47.5%) | $1.53B(-71.0%) | $11.96B(-11.3%) |
| Sep 2024 | - | $5.27B(+75.6%) | $13.48B(+14.2%) |
| Jun 2024 | - | $3.00B(+39.3%) | $11.81B(-2.2%) |
| Mar 2024 | - | $2.15B(-29.4%) | $12.07B(-18.4%) |
| Dec 2023 | $14.80B(+21.6%) | $3.05B(-15.2%) | $14.80B(-0.1%) |
| Sep 2023 | - | $3.60B(+10.4%) | $14.82B(+0.0%) |
| Jun 2023 | - | $3.26B(-33.2%) | $14.82B(+4.0%) |
| Mar 2023 | - | $4.88B(+58.9%) | $14.24B(+17.0%) |
| Dec 2022 | $12.17B(+7.7%) | $3.07B(-14.5%) | $12.17B(-2.0%) |
| Sep 2022 | - | $3.60B(+33.9%) | $12.41B(+2.4%) |
| Jun 2022 | - | $2.69B(-4.4%) | $12.12B(+8.9%) |
| Mar 2022 | - | $2.81B(-15.3%) | $11.12B(-1.5%) |
| Dec 2021 | $11.30B(-13.1%) | $3.32B(+0.5%) | $11.30B(+2.3%) |
| Sep 2021 | - | $3.30B(+94.9%) | $11.05B(-1.0%) |
| Jun 2021 | - | $1.69B(-43.2%) | $11.15B(-12.3%) |
| Mar 2021 | - | $2.98B(-2.8%) | $12.72B(-2.2%) |
| Dec 2020 | $13.00B(+2.9%) | $3.07B(-10.0%) | $13.00B(+0.6%) |
| Sep 2020 | - | $3.41B(+4.7%) | $12.91B(+2.5%) |
| Jun 2020 | - | $3.26B(-0.2%) | $12.60B(-1.1%) |
| Mar 2020 | - | $3.26B(+9.3%) | $12.74B(+0.9%) |
| Dec 2019 | $12.63B(-1.9%) | $2.99B(-3.6%) | $12.63B(-0.3%) |
| Sep 2019 | - | $3.10B(-8.8%) | $12.67B(+1.2%) |
| Jun 2019 | - | $3.40B(+7.8%) | $12.53B(-0.6%) |
| Mar 2019 | - | $3.15B(+4.1%) | $12.61B(-2.1%) |
| Dec 2018 | $12.88B(+0.2%) | $3.03B(+2.6%) | $12.88B(+0.2%) |
| Sep 2018 | - | $2.95B(-15.2%) | $12.85B(-1.7%) |
| Jun 2018 | - | $3.48B(+1.5%) | $13.07B(+0.7%) |
| Mar 2018 | - | $3.43B(+14.5%) | $12.97B(+0.9%) |
| Dec 2017 | $12.86B(+2.6%) | $3.00B(-5.5%) | $12.86B(-1.3%) |
| Sep 2017 | - | $3.17B(-6.2%) | $13.03B(-0.6%) |
| Jun 2017 | - | $3.38B(+2.1%) | $13.11B(+2.7%) |
| Mar 2017 | - | $3.31B(+4.4%) | $12.77B(+1.9%) |
| Dec 2016 | $12.53B(+12.0%) | $3.17B(-2.3%) | $12.53B(+3.6%) |
| Sep 2016 | - | $3.25B(+6.8%) | $12.10B(+2.1%) |
| Jun 2016 | - | $3.04B(-1.1%) | $11.85B(+2.1%) |
| Mar 2016 | - | $3.07B(+12.2%) | $11.60B(+3.8%) |
| Dec 2015 | $11.18B(+27.8%) | $2.74B(-8.6%) | $11.18B(+6.3%) |
| Sep 2015 | - | $3.00B(+7.3%) | $10.51B(+8.8%) |
| Jun 2015 | - | $2.79B(+5.3%) | $9.67B(+2.6%) |
| Mar 2015 | - | $2.65B(+28.0%) | $9.42B(+7.7%) |
| Dec 2014 | $8.75B(+15.5%) | $2.07B(-3.6%) | $8.75B(+4.2%) |
| Sep 2014 | - | $2.15B(-15.6%) | $8.39B(+1.2%) |
| Jun 2014 | - | $2.55B(+28.5%) | $8.29B(+8.1%) |
| Mar 2014 | - | $1.98B(+15.2%) | $7.67B(+1.3%) |
| Dec 2013 | $7.57B(+5.9%) | $1.72B(-16.1%) | $7.57B(+3.2%) |
| Sep 2013 | - | $2.05B(+6.5%) | $7.34B(+3.2%) |
| Jun 2013 | - | $1.92B(+2.1%) | $7.11B(-0.8%) |
| Mar 2013 | - | $1.88B(+26.6%) | $7.17B(+0.3%) |
| Dec 2012 | $7.15B(+22.9%) | $1.49B(-18.3%) | $7.15B(-0.3%) |
| Sep 2012 | - | $1.82B(-8.1%) | $7.17B(+15.2%) |
| Jun 2012 | - | $1.98B(+6.6%) | $6.23B(+4.4%) |
| Mar 2012 | - | $1.86B(+23.4%) | $5.97B(+2.5%) |
| Dec 2011 | $5.82B(-16.1%) | $1.51B(+71.8%) | $5.82B(+1.5%) |
| Sep 2011 | - | $877.00M(-49.1%) | $5.74B(-14.3%) |
| Jun 2011 | - | $1.72B(+0.5%) | $6.70B(-2.0%) |
| Mar 2011 | - | $1.71B(+20.5%) | $6.83B(-0.3%) |
| Dec 2010 | $6.94B(+1.6%) | $1.42B(-22.6%) | $6.85B(-0.8%) |
| Sep 2010 | - | $1.84B(-1.3%) | $6.91B(-1.6%) |
| Jun 2010 | - | $1.86B(+7.4%) | $7.02B(+1.5%) |
| Mar 2010 | - | $1.73B(+17.6%) | $6.92B(+1.3%) |
| Dec 2009 | $6.83B(+2.9%) | $1.47B(-24.4%) | $6.83B(-4.1%) |
| Sep 2009 | - | $1.95B(+10.9%) | $7.12B(+2.9%) |
| Jun 2009 | - | $1.76B(+6.9%) | $6.92B(+4.8%) |
| Mar 2009 | - | $1.65B(-6.6%) | $6.60B(-0.5%) |
| Dec 2008 | $6.64B(+11.0%) | $1.76B(+0.7%) | $6.64B(+3.0%) |
| Sep 2008 | - | $1.75B(+21.3%) | $6.44B(+6.5%) |
| Jun 2008 | - | $1.44B(-14.1%) | $6.05B(+0.5%) |
| Mar 2008 | - | $1.68B(+7.2%) | $6.02B(+0.6%) |
| Dec 2007 | $5.98B(-0.9%) | $1.57B(+15.5%) | $5.98B(-12.5%) |
| Sep 2007 | - | $1.36B(-3.9%) | $6.83B(-3.6%) |
| Jun 2007 | - | $1.41B(-14.1%) | $7.08B(-3.3%) |
| Mar 2007 | - | $1.64B(-32.1%) | $7.33B(+2.7%) |
| Dec 2006 | $6.03B(+6.1%) | $2.42B(+50.4%) | $7.13B(+18.2%) |
| Sep 2006 | - | $1.61B(-2.7%) | $6.03B(+1.8%) |
| Jun 2006 | - | $1.65B(+13.8%) | $5.93B(+2.5%) |
| Mar 2006 | - | $1.45B(+10.2%) | $5.78B(+1.7%) |
| Dec 2005 | $5.69B(+22.7%) | $1.32B(-12.2%) | $5.69B(-5.7%) |
| Sep 2005 | - | $1.50B(-0.5%) | $6.04B(+15.8%) |
| Jun 2005 | - | $1.51B(+11.2%) | $5.21B(+6.6%) |
| Mar 2005 | - | $1.36B(-18.5%) | $4.89B(+5.5%) |
| Dec 2004 | $4.64B | $1.67B(+145.0%) | $4.64B(+18.8%) |
| Sep 2004 | - | $680.00M(-42.7%) | $3.90B(-8.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2004 | - | $1.19B(+7.4%) | $4.25B(+4.9%) |
| Mar 2004 | - | $1.10B(+18.5%) | $4.05B(+7.2%) |
| Dec 2003 | $3.78B(+42.4%) | $932.00M(-9.1%) | $3.78B(+3.2%) |
| Sep 2003 | - | $1.03B(+3.8%) | $3.66B(+10.1%) |
| Jun 2003 | - | $988.50M(+18.8%) | $3.32B(+12.0%) |
| Mar 2003 | - | $832.00M(+2.1%) | $2.97B(+11.8%) |
| Dec 2002 | $2.65B(+47.7%) | $815.00M(+18.2%) | $2.65B(+25.2%) |
| Sep 2002 | - | $689.40M(+9.2%) | $2.12B(+8.5%) |
| Jun 2002 | - | $631.50M(+21.9%) | $1.95B(+6.2%) |
| Mar 2002 | - | $518.10M(+85.0%) | $1.84B(+2.3%) |
| Dec 2001 | $1.80B(+13.7%) | $280.10M(-46.4%) | $1.80B(-3.8%) |
| Sep 2001 | - | $522.90M(+1.0%) | $1.87B(+4.6%) |
| Jun 2001 | - | $517.70M(+8.7%) | $1.79B(+6.3%) |
| Mar 2001 | - | $476.40M(+35.7%) | $1.68B(+3.5%) |
| Dec 2000 | $1.58B(+5.2%) | $351.10M(-20.2%) | $1.62B(-1.7%) |
| Sep 2000 | - | $440.10M(+7.0%) | $1.65B(+2.8%) |
| Jun 2000 | - | $411.30M(-2.0%) | $1.60B(+1.9%) |
| Mar 2000 | - | $419.70M(+10.8%) | $1.58B(+4.9%) |
| Dec 1999 | $1.50B(+19.0%) | $378.80M(-4.1%) | $1.50B(+3.1%) |
| Sep 1999 | - | $395.00M(+3.5%) | $1.46B(+4.8%) |
| Jun 1999 | - | $381.60M(+10.2%) | $1.39B(+4.7%) |
| Mar 1999 | - | $346.40M(+3.8%) | $1.33B(+5.2%) |
| Dec 1998 | $1.26B(+20.5%) | $333.60M(+1.6%) | $1.26B(+7.6%) |
| Sep 1998 | - | $328.30M(+2.8%) | $1.17B(+7.4%) |
| Jun 1998 | - | $319.40M(+13.7%) | $1.09B(+3.0%) |
| Mar 1998 | - | $280.90M(+15.0%) | $1.06B(+1.3%) |
| Dec 1997 | $1.05B(+3.1%) | $244.20M(-1.5%) | $1.05B(-1.0%) |
| Sep 1997 | - | $247.90M(-13.8%) | $1.06B(-1.1%) |
| Jun 1997 | - | $287.70M(+7.5%) | $1.07B(+2.2%) |
| Mar 1997 | - | $267.60M(+5.0%) | $1.05B(+4.5%) |
| Dec 1996 | $1.02B(+20.3%) | $254.90M(-1.7%) | $1.00B(+3.5%) |
| Sep 1996 | - | $259.40M(-2.0%) | $967.10M(+3.1%) |
| Jun 1996 | - | $264.80M(+19.1%) | $937.70M(+5.3%) |
| Mar 1996 | - | $222.30M(+0.8%) | $890.50M(+5.4%) |
| Dec 1995 | $845.00M(+9.3%) | $220.60M(-4.1%) | $845.00M(+1.3%) |
| Sep 1995 | - | $230.00M(+5.7%) | $834.10M(+3.4%) |
| Jun 1995 | - | $217.60M(+23.1%) | $806.60M(+3.3%) |
| Mar 1995 | - | $176.80M(-15.7%) | $781.10M(+1.0%) |
| Dec 1994 | $773.00M(+28.4%) | $209.70M(+3.6%) | $773.30M(+8.4%) |
| Sep 1994 | - | $202.50M(+5.4%) | $713.70M(+5.9%) |
| Jun 1994 | - | $192.10M(+13.7%) | $673.80M(+6.3%) |
| Mar 1994 | - | $169.00M(+12.6%) | $634.10M(+5.3%) |
| Dec 1993 | $601.90M(+13.2%) | $150.10M(-7.7%) | $602.00M(-8.3%) |
| Sep 1993 | - | $162.60M(+6.7%) | $656.30M(+5.5%) |
| Jun 1993 | - | $152.40M(+11.3%) | $621.90M(+7.6%) |
| Mar 1993 | - | $136.90M(-33.0%) | $577.90M(+8.7%) |
| Dec 1992 | $531.70M(+266.9%) | $204.40M(+59.4%) | $531.80M(+28.5%) |
| Sep 1992 | - | $128.20M(+18.3%) | $413.70M(+16.3%) |
| Jun 1992 | - | $108.40M(+19.4%) | $355.70M(+99.3%) |
| Mar 1992 | - | $90.80M(+5.2%) | $178.50M(+23.2%) |
| Dec 1991 | $144.90M(+110.6%) | $86.30M(+22.9%) | $144.90M(+331.3%) |
| Sep 1991 | - | $70.20M(-202.0%) | $33.60M(-295.3%) |
| Jun 1991 | - | -$68.80M(-220.3%) | -$17.20M(-125.0%) |
| Mar 1991 | - | $57.20M(-328.8%) | $68.80M(+164.6%) |
| Mar 1991 | $68.80M(+67.4%) | - | - |
| Dec 1990 | - | -$25.00M(-228.9%) | $26.00M(-60.4%) |
| Sep 1990 | - | $19.40M(+12.8%) | $65.70M(+21.9%) |
| Jun 1990 | - | $17.20M(+19.4%) | $53.90M(+31.5%) |
| Mar 1990 | $41.10M(+1184.4%) | $14.40M(-2.0%) | $41.00M(-213.3%) |
| Dec 1989 | - | $14.70M(+93.4%) | -$36.20M(+22.3%) |
| Sep 1989 | - | $7.60M(+76.7%) | -$29.60M(+66.3%) |
| Jun 1989 | - | $4.30M(-106.8%) | -$17.80M(+270.8%) |
| Mar 1989 | $3.20M(-313.3%) | -$62.80M(-394.8%) | -$4.80M(-135.3%) |
| Dec 1988 | - | $21.30M(+9.8%) | $13.60M(+130.5%) |
| Sep 1988 | - | $19.40M(+12.1%) | $5.90M(-755.6%) |
| Jun 1988 | - | $17.30M(-139.0%) | -$900.00K(-83.9%) |
| Mar 1988 | -$1.50M(-225.0%) | -$44.40M(-426.5%) | -$5.60M(-132.7%) |
| Dec 1987 | - | $13.60M(+7.9%) | $17.10M(+51.3%) |
| Sep 1987 | - | $12.60M(0.0%) | $11.30M(+135.4%) |
| Jun 1987 | - | $12.60M(-158.1%) | $4.80M(-469.2%) |
| Mar 1987 | $1.20M(-25.0%) | -$21.70M(-378.2%) | -$1.30M(-127.7%) |
| Dec 1986 | - | $7.80M(+27.9%) | $4.70M(+135.0%) |
| Sep 1986 | - | $6.10M(-6.2%) | $2.00M(-41.2%) |
| Jun 1986 | - | $6.50M(-141.4%) | $3.40M(-950.0%) |
| Mar 1986 | $1.60M(-118.8%) | -$15.70M(-407.8%) | -$400.00K(-150.0%) |
| Dec 1985 | - | $5.10M(-32.0%) | $800.00K(-129.6%) |
| Sep 1985 | - | $7.50M(+177.8%) | -$2.70M(-69.0%) |
| Jun 1985 | - | $2.70M(-118.6%) | -$8.70M(-17.1%) |
| Mar 1985 | -$8.50M(+16.4%) | -$14.50M(-1006.3%) | -$10.50M(+66.7%) |
| Dec 1984 | - | $1.60M(+6.7%) | -$6.30M(-20.3%) |
| Sep 1984 | - | $1.50M(+66.7%) | -$7.90M(-16.0%) |
| Jun 1984 | - | $900.00K(-108.7%) | -$9.40M(-8.7%) |
| Mar 1984 | -$7.30M | -$10.30M | -$10.30M |
FAQ
- What is Amgen annual EBITDA?
- What is the all time high annual EBITDA for Amgen?
- What is Amgen annual EBITDA year-on-year change?
- What is Amgen quarterly EBITDA?
- What is the all time high quarterly EBITDA for Amgen?
- What is Amgen quarterly EBITDA year-on-year change?
- What is Amgen TTM EBITDA?
- What is the all time high TTM EBITDA for Amgen?
- What is Amgen TTM EBITDA year-on-year change?
What is Amgen annual EBITDA?
The current annual EBITDA of AMGN is $7.76B
What is the all time high annual EBITDA for Amgen?
Amgen all-time high annual EBITDA is $14.80B
What is Amgen annual EBITDA year-on-year change?
Over the past year, AMGN annual EBITDA has changed by -$7.04B (-47.54%)
What is Amgen quarterly EBITDA?
The current quarterly EBITDA of AMGN is $1.53B
What is the all time high quarterly EBITDA for Amgen?
Amgen all-time high quarterly EBITDA is $5.27B
What is Amgen quarterly EBITDA year-on-year change?
Over the past year, AMGN quarterly EBITDA has changed by -$1.52B (-49.92%)
What is Amgen TTM EBITDA?
The current TTM EBITDA of AMGN is $11.96B
What is the all time high TTM EBITDA for Amgen?
Amgen all-time high TTM EBITDA is $14.82B
What is Amgen TTM EBITDA year-on-year change?
Over the past year, AMGN TTM EBITDA has changed by -$2.84B (-19.20%)